US Stock MarketDetailed Quotes

VERO Venus Concept

Watchlist
  • 2.525
  • +0.015+0.60%
Trading Apr 29 12:37 ET
3.60MMarket Cap-0.04P/E (TTM)

Venus Concept Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
13.94%-11.07M
-391.86%-3.81M
25.18%-3.05M
37.23%-1.33M
51.12%-2.88M
52.34%-12.86M
77.28%-774K
-5.57%-4.08M
70.89%-2.12M
52.61%-5.89M
Net income from continuing operations
-26.78%-46.97M
28.11%-8.02M
-3.86%-9.3M
-171.33%-19.86M
-1.73%-9.79M
14.99%-37.05M
-12.17%-11.15M
38.22%-8.96M
30.36%-7.32M
-11.43%-9.62M
Operating gains losses
415.78%11.47M
-94.69%114K
--437K
25,888.10%10.92M
-85.29%5K
1,307.59%2.22M
2,726.32%2.15M
--0
--42K
--34K
Depreciation and amortization
-5.49%3.89M
-10.07%965K
-3.76%972K
-4.68%977K
-3.18%975K
-7.80%4.12M
-8.29%1.07M
-6.57%1.01M
-7.74%1.03M
-8.54%1.01M
Deferred tax
-542.03%-443K
-102.41%-168K
-54.69%-99K
21.13%-56K
-180.54%-120K
90.27%-69K
6.74%-83K
81.01%-64K
78.35%-71K
231.11%149K
Other non cash items
144.38%5.39M
38.50%1.24M
157.78%1.62M
237.46%2.05M
550.00%481K
432.85%2.21M
628.46%896K
477.98%630K
488.35%606K
-6.33%74K
Change In working capital
3.80%12.08M
-78.63%1.18M
-5.49%2.43M
49.25%3.79M
355.59%4.69M
2,690.89%11.64M
110.89%5.5M
-56.45%2.57M
269.65%2.54M
115.60%1.03M
-Change in receivables
-16.14%12.49M
-31.30%2.57M
-20.85%3.95M
-39.19%2.74M
95.04%3.23M
51.10%14.89M
-30.16%3.75M
-28.52%4.99M
536.35%4.5M
151.70%1.65M
-Change in inventory
1,477.47%4.46M
1,696.15%1.25M
219.89%651K
242.26%845K
93.27%1.72M
94.40%-324K
76.51%-78K
80.39%-543K
66.46%-594K
197.80%891K
-Change in prepaid assets
-92.95%47K
-11,308.33%-1.35M
-87.66%39K
64.40%411K
958.43%942K
-20.12%667K
-91.04%12K
-91.96%316K
-64.59%250K
102.26%89K
-Change in payables and accrued expense
6.51%-3.82M
-147.87%-628K
-22.72%-1.8M
115.35%128K
51.03%-1.51M
-1.29%-4.08M
179.23%1.31M
46.89%-1.47M
31.13%-834K
-292.89%-3.09M
-Change in other current assets
-55.07%1.42M
-109.10%-83K
148.08%75K
38.02%432K
-52.39%997K
157.20%3.16M
107.56%912K
-123.08%-156K
-97.52%313K
131.04%2.09M
-Change in other current liabilities
-13.15%-1.65M
-198.63%-436K
45.78%-270K
59.23%-232K
-189.07%-714K
-125.39%-1.46M
-101.24%-146K
-314.66%-498K
95.54%-569K
-103.79%-247K
-Change in other working capital
28.56%-868K
41.18%-150K
-194.52%-215K
-0.95%-532K
108.06%29K
-78.94%-1.22M
55.73%-255K
81.14%-73K
-346.26%-527K
-614.29%-360K
Cash from discontinued investing activities
Operating cash flow
13.94%-11.07M
-391.86%-3.81M
25.18%-3.05M
37.23%-1.33M
51.12%-2.88M
52.34%-12.86M
77.28%-774K
-5.57%-4.08M
70.89%-2.12M
52.61%-5.89M
Investing cash flow
Cash flow from continuing investing activities
-6.03%-123K
-196.30%-80K
33.33%4K
0.00%-22K
64.29%-25K
65.48%-116K
30.77%-27K
106.52%3K
76.60%-22K
55.41%-70K
Net PPE purchase and sale
-6.03%-123K
-196.30%-80K
33.33%4K
0.00%-22K
64.29%-25K
65.48%-116K
30.77%-27K
106.52%3K
76.60%-22K
55.41%-70K
Cash from discontinued investing activities
Investing cash flow
-6.03%-123K
-196.30%-80K
33.33%4K
0.00%-22K
64.29%-25K
65.48%-116K
30.77%-27K
106.52%3K
76.60%-22K
55.41%-70K
Financing cash flow
Cash flow from continuing financing activities
47.96%10.06M
188.67%3.67M
-37.34%1.8M
7.94%2M
223.04%2.59M
-15.07%6.8M
-84.57%1.27M
1,911.19%2.88M
15,333.33%1.85M
309.11%803K
Net issuance payments of debt
--9.2M
--3.67M
--1.93M
--2M
--1.61M
--0
--0
--0
--0
--0
Net common stock issuance
-86.05%987K
-99.93%1K
--0
-49.66%976K
-98.75%10K
-18.21%7.08M
-82.29%1.46M
1,911.19%2.88M
612.87%1.94M
--803K
Net other financing activities
54.18%-126K
--0
----
----
--977K
-121.77%-275K
---188K
--0
----
----
Cash from discontinued financing activities
Financing cash flow
47.96%10.06M
188.67%3.67M
-37.34%1.8M
7.94%2M
223.04%2.59M
-15.07%6.8M
-84.57%1.27M
1,911.19%2.88M
15,333.33%1.85M
309.11%803K
Net cash flow
Beginning cash position
-53.36%5.4M
-8.87%4.49M
-6.37%5.73M
-20.69%5.09M
-53.36%5.4M
-62.53%11.57M
-27.31%4.93M
-41.92%6.12M
-64.19%6.41M
-62.53%11.57M
Current changes in cash
81.78%-1.13M
-146.38%-218K
-3.93%-1.24M
320.89%645K
94.01%-309K
68.03%-6.17M
-90.19%470K
68.22%-1.2M
96.04%-292K
60.24%-5.16M
End cash Position
-20.85%4.27M
-20.85%4.27M
-8.87%4.49M
-6.37%5.73M
-20.69%5.09M
-53.36%5.4M
-53.36%5.4M
-27.31%4.93M
-41.92%6.12M
-64.19%6.41M
Free cash flow
13.76%-11.19M
-385.27%-3.89M
25.22%-3.05M
36.85%-1.35M
51.28%-2.9M
52.50%-12.98M
76.76%-801K
-4.25%-4.07M
70.96%-2.14M
52.64%-5.96M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 13.94%-11.07M-391.86%-3.81M25.18%-3.05M37.23%-1.33M51.12%-2.88M52.34%-12.86M77.28%-774K-5.57%-4.08M70.89%-2.12M52.61%-5.89M
Net income from continuing operations -26.78%-46.97M28.11%-8.02M-3.86%-9.3M-171.33%-19.86M-1.73%-9.79M14.99%-37.05M-12.17%-11.15M38.22%-8.96M30.36%-7.32M-11.43%-9.62M
Operating gains losses 415.78%11.47M-94.69%114K--437K25,888.10%10.92M-85.29%5K1,307.59%2.22M2,726.32%2.15M--0--42K--34K
Depreciation and amortization -5.49%3.89M-10.07%965K-3.76%972K-4.68%977K-3.18%975K-7.80%4.12M-8.29%1.07M-6.57%1.01M-7.74%1.03M-8.54%1.01M
Deferred tax -542.03%-443K-102.41%-168K-54.69%-99K21.13%-56K-180.54%-120K90.27%-69K6.74%-83K81.01%-64K78.35%-71K231.11%149K
Other non cash items 144.38%5.39M38.50%1.24M157.78%1.62M237.46%2.05M550.00%481K432.85%2.21M628.46%896K477.98%630K488.35%606K-6.33%74K
Change In working capital 3.80%12.08M-78.63%1.18M-5.49%2.43M49.25%3.79M355.59%4.69M2,690.89%11.64M110.89%5.5M-56.45%2.57M269.65%2.54M115.60%1.03M
-Change in receivables -16.14%12.49M-31.30%2.57M-20.85%3.95M-39.19%2.74M95.04%3.23M51.10%14.89M-30.16%3.75M-28.52%4.99M536.35%4.5M151.70%1.65M
-Change in inventory 1,477.47%4.46M1,696.15%1.25M219.89%651K242.26%845K93.27%1.72M94.40%-324K76.51%-78K80.39%-543K66.46%-594K197.80%891K
-Change in prepaid assets -92.95%47K-11,308.33%-1.35M-87.66%39K64.40%411K958.43%942K-20.12%667K-91.04%12K-91.96%316K-64.59%250K102.26%89K
-Change in payables and accrued expense 6.51%-3.82M-147.87%-628K-22.72%-1.8M115.35%128K51.03%-1.51M-1.29%-4.08M179.23%1.31M46.89%-1.47M31.13%-834K-292.89%-3.09M
-Change in other current assets -55.07%1.42M-109.10%-83K148.08%75K38.02%432K-52.39%997K157.20%3.16M107.56%912K-123.08%-156K-97.52%313K131.04%2.09M
-Change in other current liabilities -13.15%-1.65M-198.63%-436K45.78%-270K59.23%-232K-189.07%-714K-125.39%-1.46M-101.24%-146K-314.66%-498K95.54%-569K-103.79%-247K
-Change in other working capital 28.56%-868K41.18%-150K-194.52%-215K-0.95%-532K108.06%29K-78.94%-1.22M55.73%-255K81.14%-73K-346.26%-527K-614.29%-360K
Cash from discontinued investing activities
Operating cash flow 13.94%-11.07M-391.86%-3.81M25.18%-3.05M37.23%-1.33M51.12%-2.88M52.34%-12.86M77.28%-774K-5.57%-4.08M70.89%-2.12M52.61%-5.89M
Investing cash flow
Cash flow from continuing investing activities -6.03%-123K-196.30%-80K33.33%4K0.00%-22K64.29%-25K65.48%-116K30.77%-27K106.52%3K76.60%-22K55.41%-70K
Net PPE purchase and sale -6.03%-123K-196.30%-80K33.33%4K0.00%-22K64.29%-25K65.48%-116K30.77%-27K106.52%3K76.60%-22K55.41%-70K
Cash from discontinued investing activities
Investing cash flow -6.03%-123K-196.30%-80K33.33%4K0.00%-22K64.29%-25K65.48%-116K30.77%-27K106.52%3K76.60%-22K55.41%-70K
Financing cash flow
Cash flow from continuing financing activities 47.96%10.06M188.67%3.67M-37.34%1.8M7.94%2M223.04%2.59M-15.07%6.8M-84.57%1.27M1,911.19%2.88M15,333.33%1.85M309.11%803K
Net issuance payments of debt --9.2M--3.67M--1.93M--2M--1.61M--0--0--0--0--0
Net common stock issuance -86.05%987K-99.93%1K--0-49.66%976K-98.75%10K-18.21%7.08M-82.29%1.46M1,911.19%2.88M612.87%1.94M--803K
Net other financing activities 54.18%-126K--0----------977K-121.77%-275K---188K--0--------
Cash from discontinued financing activities
Financing cash flow 47.96%10.06M188.67%3.67M-37.34%1.8M7.94%2M223.04%2.59M-15.07%6.8M-84.57%1.27M1,911.19%2.88M15,333.33%1.85M309.11%803K
Net cash flow
Beginning cash position -53.36%5.4M-8.87%4.49M-6.37%5.73M-20.69%5.09M-53.36%5.4M-62.53%11.57M-27.31%4.93M-41.92%6.12M-64.19%6.41M-62.53%11.57M
Current changes in cash 81.78%-1.13M-146.38%-218K-3.93%-1.24M320.89%645K94.01%-309K68.03%-6.17M-90.19%470K68.22%-1.2M96.04%-292K60.24%-5.16M
End cash Position -20.85%4.27M-20.85%4.27M-8.87%4.49M-6.37%5.73M-20.69%5.09M-53.36%5.4M-53.36%5.4M-27.31%4.93M-41.92%6.12M-64.19%6.41M
Free cash flow 13.76%-11.19M-385.27%-3.89M25.22%-3.05M36.85%-1.35M51.28%-2.9M52.50%-12.98M76.76%-801K-4.25%-4.07M70.96%-2.14M52.64%-5.96M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Collegium Pharmaceutical
COLL
27.595
Cars.com
CARS
12.075
Halozyme Therapeutics
HALO
61.450
4
Hutchmed (China)
HCM
15.280
5
Lantheus
LNTH
104.020
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.